Semble
Provides a healthcare management platform that helps outpatient providers manage clinical, administrative, and patient workflows.
Overview
Semble builds healthcare management software for outpatient providers, supporting the operational systems used to run care delivery outside hospital settings. Its platform targets clinics and specialist providers seeking to manage healthcare workflows through a dedicated provider-focused system. The company’s positioning around outpatient care is its core market focus, distinguishing it from broader healthcare software vendors. Semble raised a €34.7 million Series C in June 2026, bringing disclosed funding to about €35 million to scale the platform.
Funding History
London’s Semble raises €34.7 million Series C to scale its healthcare management platform for outpatient providers
Frequently Asked Questions
- How much funding does AI Funding track for Semble?
- AI Funding tracks €35M for Semble across 1 funding round in this database.
- Who are Semble's investors?
- Semble's investors include Partech, Octopus Ventures, Mercia Ventures, Revaia.
- What does Semble do?
- Semble builds healthcare management software for outpatient providers, supporting the operational systems used to run care delivery outside hospital settings. Its platform targets clinics and specialist providers seeking to manage healthcare workflows through a dedicated provider-focused system. The company’s positioning around outpatient care is its core market focus, distinguishing it from broader healthcare software vendors. Semble raised a €34.7 million Series C in June 2026, bringing disclosed funding to about €35 million to scale the platform.
- Where is Semble headquartered?
- Semble is headquartered in London, UK.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
Thrive Capital has led funding rounds for OpenAI, Databricks, Perplexity, and Cursor. We analyze the firm's concentrated AI investment strategy and $25B+ portfolio.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.